HST Global, Inc. (HSTC)
- Previous Close
1.1200 - Open
0.6700 - Bid --
- Ask --
- Day's Range
0.6500 - 0.6700 - 52 Week Range
0.1000 - 1.1500 - Volume
5,700 - Avg. Volume
349 - Market Cap (intraday)
3.412M - Beta (5Y Monthly) -0.99
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer in the United States and internationally. The company also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
www.hstglobal.comRelated News
Performance Overview: HSTC
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSTC
Valuation Measures
Market Cap
3.41M
Enterprise Value
3.51M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-24.90
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-10,264.22%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-146.21k
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.53k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
33.92k
Company Insights: HSTC
HSTC does not have Company Insights